Gold Nanorod Bioconjugates for Active Tumor Targeting and Photothermal Therapy

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="631753.fig.001a" src="https://static.hindawi.com/articles/jnt/volume-2011/631753/figures/631753.fig.001a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Gold nanorod conjugation to antibody followed by PEGylation</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="631753.fig.001b" src="https://static.hindawi.com/articles/jnt/volume-2011/631753/figures/631753.fig.001b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Conjugation of Antibody to PEGylated Gold Nanorod</td></tr></table></td></tr></table>

<table>Illustration of Nanorod to Antibody Conjugation. (a) Gold nanorod conjugation to antibody followed by PEGylation and (b) conjugation of antibody to PEGylated nanorod.</table>

Journal of Nanotechnology

fig1

Figure 1

Figure 1: Gold Nanorod Bioconjugates for Active Tumor Targeting and Photothermal Therapy 